Primary cutaneous CD4‐positive small/medium T‐cell lymphoproliferative disorder: The first‐reported Latin‐American case with response to doxycycline
Abstract Primary cutaneous CD4+ small/medium T‐cell lymphoproliferative disorder is a provisional entity according to the last WHO‐EORTC classification. The treatment of choice has not yet been defined. Local therapies have been used with variable response. Doxycycline as a main treatment option is...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-12-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.2454 |
| _version_ | 1818047642571112448 |
|---|---|
| author | Claudio Escanilla Piedad Marcela Guavita Falla Carolina Cevallos Nicolás Ávalos Jobet Francisco Bobadilla Bruneau |
| author_facet | Claudio Escanilla Piedad Marcela Guavita Falla Carolina Cevallos Nicolás Ávalos Jobet Francisco Bobadilla Bruneau |
| author_sort | Claudio Escanilla |
| collection | DOAJ |
| description | Abstract Primary cutaneous CD4+ small/medium T‐cell lymphoproliferative disorder is a provisional entity according to the last WHO‐EORTC classification. The treatment of choice has not yet been defined. Local therapies have been used with variable response. Doxycycline as a main treatment option is a potential low‐cost and effective alternative for this disorder. |
| first_indexed | 2024-12-10T10:09:02Z |
| format | Article |
| id | doaj.art-2d9af0b5fb7246a69af3d68d57c88d6c |
| institution | Directory Open Access Journal |
| issn | 2050-0904 |
| language | English |
| last_indexed | 2024-12-10T10:09:02Z |
| publishDate | 2019-12-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical Case Reports |
| spelling | doaj.art-2d9af0b5fb7246a69af3d68d57c88d6c2022-12-22T01:53:11ZengWileyClinical Case Reports2050-09042019-12-017122405240910.1002/ccr3.2454Primary cutaneous CD4‐positive small/medium T‐cell lymphoproliferative disorder: The first‐reported Latin‐American case with response to doxycyclineClaudio Escanilla0Piedad Marcela Guavita Falla1Carolina Cevallos2Nicolás Ávalos Jobet3Francisco Bobadilla Bruneau4Instituto Chileno de Cabeza y Cuello Santiago ChileDepartamento de Dermatología Facultad de Medicina Universidad Nacional de Colombia Bogotá ColombiaDepartamento de Dermatología Universidad de Santiago de Chile Santiago ChileInstituto Chileno de Cabeza y Cuello Santiago ChileHospital Barros Luco Trudeau Santiago ChileAbstract Primary cutaneous CD4+ small/medium T‐cell lymphoproliferative disorder is a provisional entity according to the last WHO‐EORTC classification. The treatment of choice has not yet been defined. Local therapies have been used with variable response. Doxycycline as a main treatment option is a potential low‐cost and effective alternative for this disorder.https://doi.org/10.1002/ccr3.2454CD4‐positive T‐lymphocytecutaneous T‐cell lymphomadoxycyclinedrug repurposinglymphoproliferative disorder |
| spellingShingle | Claudio Escanilla Piedad Marcela Guavita Falla Carolina Cevallos Nicolás Ávalos Jobet Francisco Bobadilla Bruneau Primary cutaneous CD4‐positive small/medium T‐cell lymphoproliferative disorder: The first‐reported Latin‐American case with response to doxycycline Clinical Case Reports CD4‐positive T‐lymphocyte cutaneous T‐cell lymphoma doxycycline drug repurposing lymphoproliferative disorder |
| title | Primary cutaneous CD4‐positive small/medium T‐cell lymphoproliferative disorder: The first‐reported Latin‐American case with response to doxycycline |
| title_full | Primary cutaneous CD4‐positive small/medium T‐cell lymphoproliferative disorder: The first‐reported Latin‐American case with response to doxycycline |
| title_fullStr | Primary cutaneous CD4‐positive small/medium T‐cell lymphoproliferative disorder: The first‐reported Latin‐American case with response to doxycycline |
| title_full_unstemmed | Primary cutaneous CD4‐positive small/medium T‐cell lymphoproliferative disorder: The first‐reported Latin‐American case with response to doxycycline |
| title_short | Primary cutaneous CD4‐positive small/medium T‐cell lymphoproliferative disorder: The first‐reported Latin‐American case with response to doxycycline |
| title_sort | primary cutaneous cd4 positive small medium t cell lymphoproliferative disorder the first reported latin american case with response to doxycycline |
| topic | CD4‐positive T‐lymphocyte cutaneous T‐cell lymphoma doxycycline drug repurposing lymphoproliferative disorder |
| url | https://doi.org/10.1002/ccr3.2454 |
| work_keys_str_mv | AT claudioescanilla primarycutaneouscd4positivesmallmediumtcelllymphoproliferativedisorderthefirstreportedlatinamericancasewithresponsetodoxycycline AT piedadmarcelaguavitafalla primarycutaneouscd4positivesmallmediumtcelllymphoproliferativedisorderthefirstreportedlatinamericancasewithresponsetodoxycycline AT carolinacevallos primarycutaneouscd4positivesmallmediumtcelllymphoproliferativedisorderthefirstreportedlatinamericancasewithresponsetodoxycycline AT nicolasavalosjobet primarycutaneouscd4positivesmallmediumtcelllymphoproliferativedisorderthefirstreportedlatinamericancasewithresponsetodoxycycline AT franciscobobadillabruneau primarycutaneouscd4positivesmallmediumtcelllymphoproliferativedisorderthefirstreportedlatinamericancasewithresponsetodoxycycline |